In July 2012 the AXA Commercial Lines and Personal Intermediary businesses came together to form a new single organisation – AXA Commercial Lines and Personal Intermediary. Led by Amanda Blanc, the business offers brokers a more integrated and consistent approach from AXA which is focussed on their needs as a business – whatever the product. AXA Commercial Lines & Personal Intermediary provides underwriting expertise, offering a range of commercial lines and personal lines products and insurance solutions to our brokers and customers. AXA Commercial & Personal Intermediary is part of AXA Group, a worldwide leader in insurance and asset management serving 101 million clients.
AXA Research Fund secures EUR 50m funding over the next 5 years
- The AXA Research Fund will receive EUR 50m over the next five years
- The fund will focus on energy transition and women’s health for the remainder of 2018
- New endowment comes as the fund celebrates its 10th birthday
The AXA Research Fund has been granted a new EUR 50m endowment over the next five years as its looks to fund new, innovative research to better understand and manage risk.
The fund, which celebrated its 10th birthday this week, focuses on health, environment, social and economic issues as well as technology, but has two major priorities for 2018 in line with AXA’s strategy; energy transition and women’s health. Grants are awarded to researchers up to the value of EUR 125,000.
The AXA Research Fund has dedicated EUR 180m, since 2008, to fund 563 projects in 35 countries. In 2018, the fund has already supported 39 researchers covering topics such as the environment, innovation in healthcare and technology.
Since its inception, the AXA Research Fund has committed EUR 24m to 128 academics at UK universities. In the past year, grants have been awarded to Peter Joshi of the University of Edinburgh, who is studying genomic and biological basis of human lifespan in order to guide medicine and healthcare systems and Joanna Bryson, of the University of Bath, who is investigating whether robots who look like humans have a negative effect on our perception of artificial intelligence.
Thomas Buberl, CEO, AXA commented “By contributing to the progress and dissemination of science to address our societies’ challenges, the AXA Research Fund is a key pillar of our corporate responsibility, a vector of AXA’s strategy aiming at offering everyone the means to live a better life.” [Thomas Buberl, CEO, AXA.]
Marie Bogataj, Director, AXA Research said “Research can play a decisive role in the improvement of women’s specific health conditions and in facilitating solutions for their access to health services.”
If you like the content you see on youTalk-insurance why not take 20 seconds to subscribe to our free newsletter
- 12 Aug 2019
- 2 Aug 2019
- 18 Jul 2019
- 15 Jul 2019
- 14 Jul 2019
- 11 Jul 2019
- 8 Jul 2019
- 4 Jul 2019
- 1 Jul 2019
- 24 Jun 2019